Plasma 125 I-labelled fibrinogen clearance in diagnosis of deep venous thrombosis after myocardial infarction.
نویسندگان
چکیده
Plasma 125I-labelled fibrinogen clearance has been determined in 72 patients with myocardial infarction. No significant variation in clearance rates was observed whether or not deep venous thrombosis of the legs occurred. It is suggested that 125I-labelled fibrinogen clearance from the plasma is influenced by the degree of fibrinogen accumulation in the heart and by the degree of stability of the 125I binding to thefibrinogen, rather than by the presence of deep venous thrombosis of the legs.
منابع مشابه
Puerperal thromboembolic disease in "high risk" cases.
One hundred obstetric patients were studied for evidence of puerperal thromboembolic disease. Only one case of deep vein thrombosis was detected in patients thought to be in a "high risk" category because of age or operative intervention. Clinical findings were unreliable compared with measurements of (125)I-labelled fibrinogen uptake. Doppler ultrasound flow detection proved a simple screening...
متن کاملPrevention of postoperative leg vein thrombosis by electrical muscle stimulation. An evaluation with 125I-labelled fibrinogen.
In a prospective trial of preventing deep vein thrombosis electrical stimulation of the calf muscles of one leg was used in 110 patients undergoing major surgery. Deep vein thrombosis was detected by means of the (125)I-fibrinogen uptake test in nine of the stimulated legs and in 23 of the unstimulated legs. It is suggested that this technique, which is both simple and effective, should be used...
متن کاملEfficacy of fixed minidose warfarin prophylaxis in total hip replacement.
OBJECTIVE To determine whether a small fixed perioperative dose of warfarin would prevent deep vein thrombosis after total hip replacement. DESIGN Prospective, randomised, double blind placebo controlled trial. SETTING Winford Orthopaedic Hospital, Bristol. SUBJECTS 148 patients having primary total hip replacement. INTERVENTION Warfarin 1 mg given daily for one week before and three we...
متن کاملA Rare Presentation of Arterial Thrombosis after Venous Thrombosis in a Patient with Gastric Cancer
Background: Venous thromboembolism, which comprises deep vein thrombosis and pulmonary embolism and is a significant cause of morbidity and mortality among patients with cancer. The aim of the present study was to report a rare presentation of arterial thrombosis after venous thrombosis in a patient with gastric cancer. Report of the Case: A 45 year-old female patient with locally advanced gas...
متن کاملFibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients.
Venous thrombosis is a common disease, with an estimated annual incidence in the general population of 1 in 1000 persons (1). It is a major medical problem, which may cause death due to pulmonary embolism. Fibrinogen is a key component of the common clotting pathway; it is involved in the final phases of coagulation. It is also the coagulation factor whose plasma concentration is the highest (2...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- British heart journal
دوره 34 7 شماره
صفحات -
تاریخ انتشار 1972